molecules-logo

Journal Browser

Journal Browser

Nanotechnology Applied in Medicinal Chemistry

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: closed (30 November 2023)

Special Issue Editors


E-Mail Website
Guest Editor
Laboratório de Biotecnologia Farmacêutica (BioTecFarm), Departamento de Ciências Farmacêuticas, Universidade Federal da Paraíba (UFPB), João Pessoa 58051-900, Brazil
Interests: natural products; nanomaterials for biomedical applications; nanomedicine; nanoparticles; cancer
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Laboratory of Immunopathology Keizo-Asami (LIKA), Federal University of Pernambuco. 50670-901, Recife-PE, Brazil
Interests: pharmaceutical nanotechnology; lipossomes; drug delivery; colloidal carriers

Special Issue Information

Dear Colleagues,

The identification, synthesis, and development of new or existing chemical entities suitable for therapeutic use represent a big challenge to the pharmaceutical industry. The optimization of the structure and, hence, properties of molecules to improve biological interactions allows the creation of more selective medicines that display limited side effects. Furthermore, to modulate the bioavailability, metabolism, toxicity, and delivery of new chemical agents aiming at specific biological properties, nanotechnological systems can be used as advantageous alternatives. The application of nanotechnology in medicinal chemistry is based on natural biological phenomena to produce precise solutions for disease prevention, diagnosis, and treatment. This Special Issue is dedicated to publishing innovative and relevant research in the field of development, characterization, and biological activity of promising medicinal drugs delivered into nanosystems. Thus, the Special Issue will consider, but not limit its range to, the contributions of drug candidates to nanotechnology including high-throughput nanosystem design strategies and structure–activity relationship elucidation to improve the therapeutic index of drug molecules.

Prof. Dr. Francisco Humberto Xavier-Junior
Prof. Dr. Nereide Stela Santos Magalhães
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • medicinal drug
  • structure-activity relationship
  • nanosystem design
  • lipid-based nanosystems
  • polymer-based nanosystems
  • hybrid nanosystems

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop